source
- FDA signals need for GCP compliance to accept foreign clinical trial data for regulatory reviewThe U.S. Food and Drug Administration says it will only consider clinical evidence generated outside the United States if the studies were conducted according to good clinical practice standards.…
- China NewCo model pioneer sued in US over alleged trade secret theft and double-dealingA lawsuit filed in New York and later moved to federal court accuses Su Zhang, a consultant known for shaping the China "NewCo" dealmaking model, of misusing trade secrets and engaging in double-de…